论文部分内容阅读
目的分析阿德福韦酯联合甘草酸二铵治疗慢性乙型肝炎的临床疗效。方法 68例慢性乙型肝炎患者,随机分为治疗组和对照组,每组34例,治疗组给予阿德福韦酯联合甘草酸二铵治疗,对照组采用拉米夫定联合甘草酸二铵胶囊治疗,2组均以6个月为1疗程,每疗程结束作指标检测。结果治疗组和对照组的总有效率分别为76.41%和79.41%,无显著性差异。结论阿德福韦酯联合甘草酸二铵治疗慢性乙型肝炎疗效显著,且不良反应发生率和临床用药成本又低,特别适用于基层农村临床推广。
Objective To analyze the clinical efficacy of adefovir dipivoxil and diammonium glycyrrhizinate in the treatment of chronic hepatitis B patients. Methods Sixty-eight patients with chronic hepatitis B were randomly divided into treatment group and control group, with 34 cases in each group. The treatment group was treated with adefovir dipivoxil combined with diammonium glycyrrhizinate. The control group was treated with lamivudine combined with diammonium glycyrrhizinate Capsule treatment, two groups were 6 months for a course of treatment, the end of each treatment for index testing. Results The total effective rates of the treatment group and the control group were 76.41% and 79.41% respectively, with no significant difference. Conclusion adefovir dipivoxil combined with diammonium glycyrrhizinate in the treatment of chronic hepatitis B has a significant effect, and the incidence of adverse reactions and the cost of clinical medication is low, which is especially suitable for the promotion of primary rural clinics.